Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Friedrich Böttcher"'
Publikováno v:
Clinical Drug Investigation. 31:27-41
Background: Vardenafil is a potent and highly selective oral phosphodiesterase type 5 (PDE-5) inhibitor that has been shown in numerous clinical trials and post-marketing surveillance studies to be safe and effective for improving erectile function i
Publikováno v:
European Journal of Clinical Pharmacology. 63:1123-1128
BAY 63-9044 is a new full 5-HT(1A)-agonist with functional dopamine agonist properties aimed for the treatment of Parkinson's disease. This first-in-man study investigated the pharmacodynamics, safety and tolerability as well as the pharmacokinetics
Publikováno v:
Clinical Drug Investigation. 25:115-123
Objective: To investigate the pharmacokinetics of intravenous (IV) repinotan, a potent selective full serotonin (5-HT1a) receptor agonist, after administration of escalating doses/infusion rates to healthy volunteers with extensive or poor metabolise
Publikováno v:
Clinical Pharmacokinetics. 40:39-48
To determine the effect of concomitant administration of the antacid Maalox 70 or the histamine H2 receptor antagonist ranitidine on the bioavailability of moxifloxacin.These were nonblinded, randomised, crossover studies performed in healthy volunte
Publikováno v:
Cellular and molecular life sciences : CMLS. 67(18)
Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that facilitates the transfer of cholesteryl esters from the atheroprotective high density lipoprotein (HDL) to the proatherogenic low density lipoprotein cholesterol (LDL) and very l